Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · IEX Real-Time Price · USD
7.47
-0.48 (-6.04%)
At close: Jul 2, 2024, 4:00 PM
8.04
+0.57 (7.63%)
After-hours: Jul 2, 2024, 7:49 PM EDT
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $316.88 million as of July 2, 2024. Its market cap has increased by 37.30% in one year.
Market Cap
316.88M
Enterprise Value
314.38M
1-Year Change
37.30%
Ranking
Category
Stock Price
$7.47
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.60M to $316.88M, a decrease of -27.42%. That is a compound annual growth rate of -5.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 316.90M | 2.92% |
| Dec 29, 2023 | 307.90M | 172.48% |
| Dec 30, 2022 | 113.00M | -55.18% |
| Dec 31, 2021 | 252.10M | -15.32% |
| Dec 31, 2020 | 297.70M | -27.32% |
| Dec 31, 2019 | 409.60M | 95.61% |
| Dec 31, 2018 | 209.40M | -52.04% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 314.16M |
| Korro Bio | 314.08M |
| DocGo | 313.84M |
| Nevro | 309.26M |
| TScan Therapeutics | 309.25M |
| ADC Therapeutics | 304.07M |
| Spok Holdings | 299.84M |
| SOPHiA GENETICS | 299.42M |